The 11th of June, at the gala event of the EuroNanoForum2015 in Riga, NAMDIATREAM has been awarded as the best of over 1 000 projects launched under the EU Funding Instruments in the field of nanotechnologies and advanced materials!

NAMDIATREAM has successfully developed innovative diagnostic devices for the early diagnosis of 3 common cancer types (lung, breast and prostate) representing more than 4,5 million worldwide cancer cases in the year 2012. NAMDIATREAM technology is based on cutting edge nanotechnology-based tools for multi-modal detection of biomarkers, permitting identification of cells indicative of early disease onset in a high-specificity and throughput format in clinical, laboratory and point-of-care devices. INNOVA has been in charge of project management, has coordinated the development of the strategic plan for the exploitation of project results and has delivered professional training workshops related to Technology Transfer and IPR management and valorisation.